Prevtec Microbia Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 17
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $59.9M
Latest Deal Amount

Prevtec Microbia General Information

Description

Developer of vaccines and drug technologies designed for bacterial diseases in food animals. The company's products offer sustainable solutions that release enterotoxins that trigger the transport of fluid and electrolytes from the body to the animal's intestines leading to diarrhoea and dehydration, enabling clients to antibiotics to improve animal health, production and food safety.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Other Agriculture
Parent Company
Elanco
Primary Office
  • 393 rue Saint-Jacques
  • Office 247
  • Montreal, Quebec H2Y 1N9
  • Canada
+1 (514) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prevtec Microbia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 31-Jul-2019 $59.9M 000.00 000.00 Completed Generating Revenue
7. Debt - General 31-Dec-2017 00.000 000.00 Completed Generating Revenue
6. Later Stage VC 21-Mar-2017 00.000 000.00 Completed Generating Revenue
5. Later Stage VC 21-Sep-2015 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 13-Mar-2015 00.000 00.000 Completed Generating Revenue
3. Later Stage VC 23-Nov-2011 000 000 Completed Generating Revenue
2. Early Stage VC 01-Jan-2007 Completed Startup
1. Early Stage VC Completed Startup
To view Prevtec Microbia’s complete valuation and funding history, request access »

Prevtec Microbia Executive Team (5)

Name Title Board Seat Contact Info
Michel Fortin Chief Executive Officer & President
Christian Roy Director of Finance
Eric Nadeau Ph.D Board Member, Co-Founder & Vice President, Scientific Affairs
You’re viewing 3 of 5 executive team members. Get the full list »

Prevtec Microbia Board Members (15)

Name Representing Role Since
Andre Halley Prevtec Microbia Chairman 000 0000
Bertrand Bolduc Self Board Member 000 0000
Daniel Cyr Telesystem Board Member 000 0000
Eric Nadeau Ph.D Prevtec Microbia Board Member, Co-Founder & Vice President, Scientific Affairs 000 0000
Jacques Perreault Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Prevtec Microbia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prevtec Microbia Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accès Capital Québec Venture Capital Minority 000 0000 000000 0
Desjardins Capital Corporate Venture Capital Minority 000 0000 000000 0
Echo Capital PE/Buyout Minority 000 0000 000000 0
Groupe Jafaco Gestion Corporation Minority 000 0000 000000 0
Grupo Fuertes Holding Company Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »